Your browser doesn't support javascript.
loading
Nomogram predicting survival as a selection criterion for postmastectomy radiotherapy in patients with T1 to T2 breast cancer with 1 to 3 positive lymph nodes.
Tang, Yu; Zhang, Yu-Jing; Zhang, Na; Shi, Mei; Wen, Ge; Cheng, Jing; Wang, Hong-Mei; Liu, Min; Wang, Xiao-Hu; Guo, Qi-Shuai; Wu, Hong-Fen; Ma, Chang-Ying; Jin, Jing; Liu, Yue-Ping; Song, Yong-Wen; Fang, Hui; Ren, Hua; Wang, Shu-Lian; Li, Ye-Xiong.
Affiliation
  • Tang Y; State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Zhang YJ; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Zhang N; Department of Radiation Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China.
  • Shi M; Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Wen G; Department of Radiation Oncology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Cheng J; Department of Breast Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Wang HM; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Liu M; Department of Radiation Oncology, First Hospital of Jilin University, Changchun, China.
  • Wang XH; Department of Radiation Oncology, Gansu Cancer Hospital, Lanzhou, China.
  • Guo QS; Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing Cancer Institute, Chongqing Cancer Hospital, Chonqing, China.
  • Wu HF; Department of Radiation Oncology, Jilin Cancer Hospital, Changchun, China.
  • Ma CY; Department of Radiation Oncology, First Hospital of Qiqihaer, Qiqihaer, China.
  • Jin J; State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Liu YP; State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Song YW; State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Fang H; State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Ren H; State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Wang SL; State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Li YX; State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Cancer ; 126 Suppl 16: 3857-3866, 2020 08 15.
Article in En | MEDLINE | ID: mdl-32710662
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Radiotherapy, Adjuvant / Nomograms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Cancer Year: 2020 Document type: Article Affiliation country: China Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Radiotherapy, Adjuvant / Nomograms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Cancer Year: 2020 Document type: Article Affiliation country: China Country of publication: United States